Structure-activity relationships of astemizole derivatives for inhibition of store operated Ca2+ channels and exocytosis.
The effects of a series of analogues of the antiallergic drug astemizole on the exocytosis of the enzyme beta-hexosaminidase were studied in a mast cell model, the rat basophilic leukemia (RBL-2H3) cell. Besides differences in the effects on Fc epsilonRI receptor-stimulated exocytosis, changes were also observed in Ca2+ influx and in the perturbation of the cell membrane. A strong correlation was found between the effects on antigen- and thapsigargin-stimulated 45Ca2+ influx. Furthermore, the inhibition of 45Ca2+ influx was correlated with the inhibition of beta-hexosaminidase release and membrane stabilization. It is concluded that the astemizole analogues are capable of inhibiting mast cell beta-hexosaminidase release through inhibition of Ca2+-store-operated Ca2+ channels (SOC). Compounds with high lipophilicity also released Ca2+ from intracellular stores. Lowering of the hydrophobicity by introduction of nitrogens or truncation at different sites in the astemizole structure decreased inhibitory activity on SOC channels. The inhibition of SOC channels cannot completely be ascribed to non-specific membrane effects. The piperidinyl-benzimidazole moiety was found to be important for inhibition of SOC channels. The observed differences in activity possibly depend on the way the compounds penetrate the membrane bilayer. Astemizole is an interesting new tool to study SOC channels and can be a lead for the design of mast cell-stabilizing antiallergic drugs.
Department of Pharmaceutical Chemistry, Utrecht Institute for Pharmaceutical Sciences, Faculty of Pharmacy, Utrecht University, The Netherlands.
M J
MJ
Fischer
J J
JJ
Paulussen
J P
JP
Tollenaere
N J
NJ
De Mol
L H
LH
Janssen
D000818:Animals; D016589:Astemizole / Q000031:analogs & derivatives* / Q000494:pharmacology*; D015220:Calcium Channels / Q000187:drug effects / Q000378:metabolism*; D002132:Calcium Radioisotopes; D002417:Cattle; D002478:Cells, Cultured; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000378:metabolism; D004912:Erythrocytes / Q000187:drug effects; D005089:Exocytosis / Q000187:drug effects*; D006461:Hemolysis / Q000187:drug effects; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D007038:Hypotonic Solutions / Q000494:pharmacology; D007202:Indicators and Reagents; D051381:Rats; D013329:Structure-Activity Relationship; D001619:beta-N-Acetylhexosaminidases / Q000378:metabolism
D015220:Calcium Channels; D002132:Calcium Radioisotopes; D006634:Histamine H1 Antagonists; D007038:Hypotonic Solutions; D007202:Indicators and Reagents; D016589:Astemizole; D001619:beta-N-Acetylhexosaminidases